Bevacizumab Biosimilar Equally Effective in Metastatic Colorectal Cancer
The biosimilar version of bevacizumab (Encoda) was found to be equally effective in treating metastatic colorectal cancer (mCRC) when compared with reference bevacizumab (Avastin), according to a study published in Clinical Medicine Insights: Oncology.1 CRC is among the most common […]
Bevacizumab Biosimilar Equally Effective in Metastatic Colorectal Cancer Read More »